• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

推动临床试验和生活质量国际合作的边界:肿瘤学的经验和欧洲议会的立法。

Moving the boundaries of international collaboration on clinical trials and QoL: experiences in oncology and legislation within the European Parliament.

机构信息

EORTC, Avenue Mounier, 83/11,1200 Brussels, Belgium.

出版信息

Expert Rev Pharmacoecon Outcomes Res. 2013 Feb;13(1):43-5. doi: 10.1586/erp.12.91.

DOI:10.1586/erp.12.91
PMID:23402444
Abstract

The European Organisation for Research and Treatment of Cancer undertook another successful event with their third annual conference addressing quality of life matters in cancer clinical trials. More than 40 presentations were made over a 3-day period hosted at the European Parliament on 17-20 October 2012, in Brussels. The conference managed to get speakers and policy makers together to debate all the key issues in cancer clinical trials, design and reporting, including future policy and regulatory concerns. This meeting set the stage for future research and policy meetings to give greater visibility to quality of life as an outcome in clinical trials within the world of EU legislators.

摘要

欧洲癌症研究与治疗组织成功举办了第三届年度会议,该会议主要探讨癌症临床试验中的生活质量问题。2012 年 10 月 17 日至 20 日,会议在布鲁塞尔的欧洲议会举行,为期 3 天,共进行了 40 多次演讲。会议成功邀请演讲者和政策制定者共同讨论癌症临床试验、设计和报告中的所有关键问题,包括未来的政策和监管问题。此次会议为未来的研究和政策会议奠定了基础,旨在使生活质量作为欧盟立法者临床试验中的一个结果更加引人注目。

相似文献

1
Moving the boundaries of international collaboration on clinical trials and QoL: experiences in oncology and legislation within the European Parliament.推动临床试验和生活质量国际合作的边界:肿瘤学的经验和欧洲议会的立法。
Expert Rev Pharmacoecon Outcomes Res. 2013 Feb;13(1):43-5. doi: 10.1586/erp.12.91.
2
Quality of life in cancer clinical trials: researchers, patients and policy makers.癌症临床试验中的生活质量:研究人员、患者和政策制定者。
Expert Rev Pharmacoecon Outcomes Res. 2011 Dec;11(6):661-5. doi: 10.1586/erp.11.84.
3
Regulating clinical trials in Europe.
Lancet Oncol. 2013 May;14(6):453-4. doi: 10.1016/S1470-2045(13)70071-8. Epub 2013 Mar 21.
4
European Organisation for Research and Treatment of Cancer's point of view.欧洲癌症研究与治疗组织的观点。
Lancet. 2003 Aug 23;362(9384):663. doi: 10.1016/S0140-6736(03)14163-3.
5
The need for proportionate regulation of clinical trials.
Lancet Oncol. 2013 May;14(6):454-5. doi: 10.1016/S1470-2045(13)70077-9. Epub 2013 Mar 21.
6
Summary report of the ECHTA/ECAHI project. European Collaboration for Health Technology Assessment/Assessment of Health Interventions.ECHTA/ECAHI项目总结报告。欧洲卫生技术评估协作组织/卫生干预评估。
Int J Technol Assess Health Care. 2002 Spring;18(2):218-37. doi: 10.1017/s0266462302000247.
7
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA.关于欧洲卫生技术评估的法规提案 - HTA 领域的政策制定者、支付者和学者的意见。
Expert Rev Pharmacoecon Outcomes Res. 2019 Jun;19(3):251-261. doi: 10.1080/14737167.2019.1575730. Epub 2019 Feb 15.
8
Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes.应对癌症临床试验中的行政和监管负担:美国临床肿瘤学会和美国癌症研究所协会主办的利益相关者调查与研讨会总结
J Clin Oncol. 2016 Nov 1;34(31):3796-3802. doi: 10.1200/JCO.2016.69.6781.
9
Dream vs. reality: seven case-studies on the desirability and feasibility of cross-border hospital collaboration in Europe.梦境与现实:欧洲跨境医院合作的可取性和可行性的七个案例研究。
Soc Sci Med. 2014 Sep;117:18-24. doi: 10.1016/j.socscimed.2014.07.015. Epub 2014 Jul 7.
10
The European clinical trials regulation (No 536/2014): changes and challenges.《欧洲临床试验法规(No 536/2014):变化与挑战》。
Expert Rev Clin Pharmacol. 2019 Nov;12(11):1027-1032. doi: 10.1080/17512433.2019.1680282. Epub 2019 Oct 21.